Scholars Central

Short communicationPublished 2018

Progenitor Endothelial Cells in Pulmonary Arterial Hypertension

Authors: Alexander Berezin

Journal of General Practice

Volume 6 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pulmonary artery hypertension (PAH) is common cardio-pulmonary phenomenon associated with higher risk of premature death and disability. Several previous studies have shown that decreased number of circulating endothelial progenitor cells (EPCs) correlated well with vascular remodeling and impaired pulmonary artery function. Moreover, a deep deficiency of EPC characterized a poor clinical outcomes in PAH individuals. There is large body of evidence regarding that the EPCs could be not just biomarker of endothelial dysfunction, but a target of PAH therapy. However, improvement of PAH severity associated with increasing number of circulating EPC with angiopoetic phenotype accompanying sildenafil care. The short communication is depicted the predictive role of EPCs in risk stratification in PAH patients and possibilities to use EPC-based care aimed improving clinical outcomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of General Practice.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of General Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Alexander Berezin”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels